Diabetes campaign urges active lifestyle

INDIANAPOLIS: Amylin Pharmaceuticals and Eli Lilly and Company launched the BYETTA Let's Talk Campaign last week, hoping to educate people with type 2 diabetes about the importance about staying active and taking the right medications.

INDIANAPOLIS: Amylin Pharmaceuticals and Eli Lilly and Company launched the BYETTA Let's Talk Campaign last week, hoping to educate people with type 2 diabetes about the importance about staying active and taking the right medications.

The campaign is set to visit 10 cities over the course of the summer, each one in conjunction with a popular community event. The campaign's kickoff last week, for example, took place at the New England Spring Flower Show. As part of the campaign actress Delta Burke will serve as a spokesperson, talking to the public about her experience with the disease and how BYETTA helps her manage it.

"We're trying to demystify it a little bit in a friendly atmosphere, perhaps providing them with information in a manner that is a little bit different for them." said Jamaison Schuler, senior communications associate at Eli Lilly.

BYETTA was approved by the Food and Drug Administration in April 2005, with the two drug companies co-developing and co-promoting it. Manning Selvage & Lee is assisting with the campaign.

As part of the Let's Talk campaign Chris Smith, The Diabetic Chef, will share recipes with attendees and help people understand how to prepare healthy and tasty meals for diabetes sufferers. A fitness trainer will also be on hand to provide tips on how to incorporate physical activity into your daily life. A diabetes educator will speak to patients one on one about the medication.

ByettaLetsTalk.com, will also provide diabetes friendly recipes and a diary of the tour from Delta Burke. Schuler says the campaign is an effort to talk to people about how to better cope with the disease.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.